Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: The phase 1 TRIBE trial
Kyrillus s. Shohdy, Manon Pillai, Kirellos s. Abbas, Jennifer Allison, Tom Waddell, Emma Darlington, Simrah Mohammad, Simon Hood, Sophie Atkinson, Kathryn Simpson, Derrick Morgan, Paul Nathan, Elaine Kilgour, Caroline Dive, Fiona Thistlethwaite
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: The phase 1 TRIBE trial'. Together they form a unique fingerprint.